135 related articles for article (PubMed ID: 36407358)
21. Effective anticancer agents based-on two Pillar[5]arene derivatives for pancreas cancer cell lines: synthesis, apoptotic effect, caspase pathway.
Karaselek MA; Kuccukturk S; Duran T; Kursunlu AN; Ozmen M; Bozdag C; Alkan S; Varman A; Yildirim MA; Kucukkartallar T; Vatansev C
Invest New Drugs; 2023 Apr; 41(2):202-209. PubMed ID: 36905565
[TBL] [Abstract][Full Text] [Related]
22. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
23. Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis.
Jing Y; Liang W; Liu J; Zhang L; Wei J; Zhu Y; Yang J; Ji K; Zhang Y; Huang Z
Pathol Res Pract; 2019 Nov; 215(11):152564. PubMed ID: 31547977
[TBL] [Abstract][Full Text] [Related]
24. Activity guided isolation and modification of juglone from Juglans regia as potent cytotoxic agent against lung cancer cell lines.
Zhang XB; Zou CL; Duan YX; Wu F; Li G
BMC Complement Altern Med; 2015 Nov; 15():396. PubMed ID: 26530090
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
26. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.
Johnson SK; Ramani VC; Hennings L; Haun RS
Cancer; 2007 May; 109(9):1811-20. PubMed ID: 17354228
[TBL] [Abstract][Full Text] [Related]
27. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1alpha enhances integrin alpha(6)beta(1) expression and metastatic capability of human pancreatic cancer.
Sawai H; Funahashi H; Yamamoto M; Okada Y; Hayakawa T; Tanaka M; Takeyama H; Manabe T
Oncology; 2003; 65(2):167-73. PubMed ID: 12931024
[TBL] [Abstract][Full Text] [Related]
29. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway.
Park M; Upton D; Blackmon M; Dixon V; Craver S; Neal D; Perkins D
BMC Complement Altern Med; 2018 Feb; 18(1):71. PubMed ID: 29463243
[TBL] [Abstract][Full Text] [Related]
30. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.
Cao L; Liu J; Zhang L; Xiao X; Li W
Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503
[TBL] [Abstract][Full Text] [Related]
31. A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
Pan Y; Zheng M; Zhong L; Yang J; Zhou S; Qin Y; Xiang R; Chen Y; Yang SY
Mol Cancer Ther; 2015 Feb; 14(2):407-18. PubMed ID: 25519702
[TBL] [Abstract][Full Text] [Related]
32. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
33. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
[TBL] [Abstract][Full Text] [Related]
34. Alteration of integrins by interleukin-1alpha in human pancreatic cancer cells.
Sawai H; Yamamoto M; Okada Y; Sato M; Akamo Y; Takeyama H; Manabe T
Pancreas; 2001 Nov; 23(4):399-405. PubMed ID: 11668210
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.
Huang H; Zhang Y; Xu X; Liu Y; Zhao J; Ma L; Lei J; Ge W; Li N; Ma E; Li Y; Yuan L
Bioorg Med Chem Lett; 2023 Jan; 80():129087. PubMed ID: 36427655
[TBL] [Abstract][Full Text] [Related]
36. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
37. Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway.
Fang F; Chen S; Ma J; Cui J; Li Q; Meng G; Wang L
Oncol Lett; 2018 Aug; 16(2):2579-2584. PubMed ID: 30013652
[TBL] [Abstract][Full Text] [Related]
38. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.
Aikawa T; Gunn J; Spong SM; Klaus SJ; Korc M
Mol Cancer Ther; 2006 May; 5(5):1108-16. PubMed ID: 16731742
[TBL] [Abstract][Full Text] [Related]
39. Targeted juglone blocks the invasion and metastasis of HPV-positive cervical cancer cells.
Zhao X; Zhu W; Zhang R; Zhang M; Zhao J; Hou J; Zhang W
J Pharmacol Sci; 2019 Jul; 140(3):211-217. PubMed ID: 31445828
[TBL] [Abstract][Full Text] [Related]
40. Effects of heavy water (D2O) on human pancreatic tumor cells.
Hartmann J; Bader Y; Horvath Z; Saiko P; Grusch M; Illmer C; Madlener S; Fritzer-Szekeres M; Heller N; Alken RG; Szekeres T
Anticancer Res; 2005; 25(5):3407-11. PubMed ID: 16101156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
